Skip to main content
PatientsReferrer
 
Request Appointment
Image
https://www.qscan.com.au/wp-content/uploads/2016/07/Dr-Aziz-Osman-website-e1698968540179.png

Dr Aziz
Osman

BSc, MBBS, FRANZCR
Director of Qscan Group Holdings Pty Ltd | Radiologist
Specialties and interests
  • Musculoskeletal radiology
  • Sports medicine imaging
  • MRI
  • Image-guided musculoskeletal injections
About

Dr Aziz Osman is a radiologist at Qscan Radiology Clinics. He was awarded a Bachelor of Medicine, Bachelor of Surgery from the University of Queensland in 2007. 

Aziz also completed a Bachelor of Science degree at the University of Queensland, graduating in 2003 with majors in Biomedical Science and Pharmacology. 

His post-graduate training in radiology was undertaken at the Princess Alexandra Hospital, Brisbane.
 

Fellowships
  • Cross-sectional radiology with a special interest in oncology imaging, Princess Alexandra Hospital, 2014
  • Musculoskeletal imaging with a special interest in sports medicine musculoskeletal intervention, Qscan Radiology Clinics, 2015
Other positions
  • Director, Qscan Group Holdings Pty Ltd

News & Articles

 

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.